- Home
- PTHL vs GCTS Comparison
PTHL vs GCTS Comparison
Compare PTHL & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- GCTS
- Stock Information
- Founded
- PTHL 1998
- GCTS 1998
- Country
- PTHL China
- GCTS United States
- Employees
- PTHL N/A
- GCTS N/A
- Industry
- PTHL
- GCTS Blank Checks
- Sector
- PTHL
- GCTS Finance
- Exchange
- PTHL Nasdaq
- GCTS Nasdaq
- Market Cap
- PTHL 85.4M
- GCTS 82.5M
- IPO Year
- PTHL 2024
- GCTS N/A
- Fundamental
- Price
- PTHL $0.63
- GCTS $1.26
- Analyst Decision
- PTHL
- GCTS Strong Buy
- Analyst Count
- PTHL 0
- GCTS 1
- Target Price
- PTHL N/A
- GCTS $5.00
- AVG Volume (30 Days)
- PTHL 3.5M
- GCTS 206.6K
- Earning Date
- PTHL 01-01-0001
- GCTS 08-12-2025
- Dividend Yield
- PTHL N/A
- GCTS N/A
- EPS Growth
- PTHL N/A
- GCTS N/A
- EPS
- PTHL N/A
- GCTS N/A
- Revenue
- PTHL $448,196.00
- GCTS $6,073,000.00
- Revenue This Year
- PTHL N/A
- GCTS $133.55
- Revenue Next Year
- PTHL N/A
- GCTS $347.37
- P/E Ratio
- PTHL N/A
- GCTS N/A
- Revenue Growth
- PTHL N/A
- GCTS N/A
- 52 Week Low
- PTHL $0.60
- GCTS $0.90
- 52 Week High
- PTHL $32.00
- GCTS $3.84
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- GCTS 40.91
- Support Level
- PTHL N/A
- GCTS $1.21
- Resistance Level
- PTHL N/A
- GCTS $1.45
- Average True Range (ATR)
- PTHL 0.00
- GCTS 0.11
- MACD
- PTHL 0.00
- GCTS -0.02
- Stochastic Oscillator
- PTHL 0.00
- GCTS 15.94
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.